BioTech/Drugs - Cambridge, MA, US
GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to enable new therapies for preserving and restoring vision.
Gmail
Varnish
Wix
Mobile Friendly
Google Cloud Hosting